COVID-19 in MS patients: susceptibility and severity risk factors

被引：0
|
作者：
Zabalza, A. [1 ]
Tagliani, P. [1 ]
Cardenas-Robledo, S. [1 ]
Arrambide, G. [1 ]
Otero-Romero, S. [2 ]
Carbonell-Mirabent, P. [1 ]
Rodriguez, M. [1 ]
Rodriguez-Acevedo, B. [1 ]
Restrepo-Vera, J. L. [2 ]
Resina-Salles, M. [1 ]
Midaglia, L. [3 ]
Vidal-Jordana, A. [1 ]
Rio, J. [1 ]
Galan, I. [1 ]
Castillo, J. [4 ]
Cobo Calvo, A. [1 ]
Comabella, M. [1 ]
Nos, C. [1 ]
Sastre-Garriga, J. [1 ]
Tintore, M. [1 ]
Montalban, X. [1 ]
机构：
[1] Vall dHebron Univ Campus, Multiple Sclerosis Ctr Catalonia Cemcat, Dept Neurol Neuroimmunol, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] Vall Hebron Univ Hosp, Dept Neurol Neuroimmunol, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona, Spain
[4] Neuroimmunol & Multiple Sclerosis Unit Girona, Girona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB1168
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [1] COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
    Zabalza, Ana
    Cardenas-Robledo, Simon
    Tagliani, Paula
    Arrambide, Georgina
    Otero-Romero, Susana
    Carbonell-Mirabent, Pere
    Rodriguez-Barranco, Marta
    Rodriguez-Acevedo, Breogan
    Restrepo Vera, Juan Luis
    Resina-Salles, Mireia
    Midaglia, Luciana
    Vidal-Jordana, Angela
    Rio, Jordi
    Galan, Ingrid
    Castillo, Joaquin
    Cobo-Calvo, Alvaro
    Comabella, Manuel
    Nos, Carlos
    Sastre-Garriga, Jaume
    Tintore, Mar
    Montalban, Xavier
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (10) : 3384 - 3395
  • [2] Risk Factors for Development and Severity of COVID-19 in COPD Patients
    Bonato, Matteo
    Semenzato, Umberto
    Tine, Mariaenrica
    Bazzan, Erica
    Damin, Marco
    Biondini, Davide
    Casara, Alvise
    Romagnoli, Micaela
    Turato, Graziella
    Cosio, Manuel G.
    Saetta, Marina
    Baraldo, Simonetta
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [3] COVID-19 in Elderly Patients: Risk Factors for Disease Severity
    Korkmaz, Pinar
    Ozatag, Duru Mistanoglu
    Aslan, Halil
    Toka, Onur
    Gulcan, Aynur
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (01): : 7 - 17
  • [4] Susceptibility and severity of COVID-19 in patients treated
    Salvarani, Carlo
    Bajocchi, Gianluigi
    Mancuso, Pamela
    Galli, Elena
    Muratore, Francesco
    Boiardi, Luigi
    Catanoso, Mariagrazia
    Pipitone, Nicolo
    Cassone, Giulia
    Girolimetto, Nicolo
    Croci, Stefania
    Cimino, Luca
    Gradellini, Federeica
    Beltrami, Marina
    Di Lernia, Vito
    Dolci, Giovammi
    Massari, Marco
    Marata, Anna Maria
    Costantini, Massimo
    Rossi, Paolo Giorgi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 986 - 988
  • [5] Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis
    Leong, Aaron
    Cole, Joanne B.
    Brenner, Laura N.
    Meigs, James B.
    Florez, Jose C.
    Mercader, Josep M.
    [J]. PLOS MEDICINE, 2021, 18 (03)
  • [6] Host Genetic Risk Factors Associated with COVID-19 Susceptibility and Severity in Vietnamese
    Vu Phuong Nhung
    Nguyen Dang Ton
    Tran Thi Bich Ngoc
    Ma Thi Huyen Thuong
    Nguyen Thi Thanh Hai
    Kim Thi Phuong Oanh
    Le Thi Thu Hien
    Pham Ngoc Thach
    Nong Van Hai
    Nguyen Hai Ha
    [J]. GENES, 2022, 13 (10)
  • [7] Risk Factors Associated with the Severity of COVID-19
    Martono
    Fatmawati, Fitri
    Mulyanti, Sri
    [J]. MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2023, 30 (03): : 84 - 92
  • [8] Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD
    Esmaeili, Sara
    Abbasi, Mohammad Hossein
    Abolmaali, Meysam
    Mojtahed, Mohammad
    Alavi, Seyedeh Niloufar Rafiei
    Soleimani, Sevim
    Mokhtari, Mahisa
    Hatam, Jaber
    Khotbehsara, Samaneh Tanhapour
    Motamed, Mohammad Reza
    Joghataei, Mohammad Taghi
    Mirzaasgari, Zahra
    Moghaddasi, Mehdi
    [J]. BMC NEUROLOGY, 2021, 21 (01)
  • [9] Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD
    Sara Esmaeili
    Mohammad Hossein Abbasi
    Meysam Abolmaali
    Mohammad Mojtahed
    Seyedeh Niloufar Rafiei Alavi
    Sevim Soleimani
    Mahisa Mokhtari
    Jaber Hatam
    Samaneh Tanhapour Khotbehsara
    Mohammad Reza Motamed
    Mohammad Taghi Joghataei
    Zahra Mirzaasgari
    Mehdi Moghaddasi
    [J]. BMC Neurology, 21
  • [10] COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy
    Bellino, Stefania
    Punzo, Ornella
    Rota, Maria Cristina
    Del Manso, Martina
    Urdiales, Alberto Mateo
    Andrianou, Xanthi
    Fabiani, Massimo
    Boros, Stefano
    Vescio, Fenicia
    Riccardo, Flavia
    Bella, Antonino
    Filia, Antonietta
    Rezza, Giovanni
    Villani, Alberto
    Pezzotti, Patrizio
    [J]. PEDIATRICS, 2020, 146 (04)
12345